Pharmaceutical Technology Europe spoke with Piero Iamartino, R&D director at Micro-Macinazione, about the role of micronization in pharmaceutical manufacturing. Poor bioavailability is often a result ...

Emerging methods could provide alternative ways of producing inhalable drug particles. Ask any manufacturer what process it uses to make inhalable drug particles, and the answer is likely to be ...

Microsize, a U.S.-based CDMO that specializes in particle size reduction and control technologies, has linked with Swiss equipment provider Schedio Group to acquire a Lonza micronization facility for ...

The Swiss fine chemicals giant Lonza has acquired Micro-Macinazione, a specialist in custom micronization of active pharmaceutical ingredients and other fine chemicals. Based in the south of ...

QUAKERTOWN, Pa.--(BUSINESS WIRE)--Microsize today announced the launch of its business as an independent company to support solubility and bioavailability enhancement via particle reduction ...

QUAKERTOWN, PA & MONTEGGIO, Switzerland — Microsize said it has agreed to acquire Micro-Macinazione, a Lonza-operated micronization facility in Monteggio, Switzerland, marking the company’s second ...

Xcelience provides the company with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms Powdersize brings micronization capabilities that augment ...

Microsize, a leading CDMO specializing in particle size reduction and control technologies, today announced it has signed an agreement to acquire Micro-Macinazione (Mic Mac), a dedicated micronization ...